Anthim Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Description

Anthim is a monoclonal antibody used to treat inhalational anthrax caused by Bacillus anthracis infection. It works by binding to the anthrax toxin, preventing it from entering cells and causing damage.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of anthim include adult and pediatric formulations. Anthim (obiltoxaximab) is indicated for use in adults as part of the treatment regimen for inhalational anthrax caused by Bacillus anthracis. Its clinical indications include treating inhalational anthrax, providing post-exposure prophylaxis (PEP) for inhalational anthrax, and its use in both pediatric and adult populations. The various distribution channels include hospitals, drug stores, and other applications.

The anthim market research report is one of a series of new reports from The Business Research Company that provides anthim market statistics, including anthim industry global market size, regional shares, competitors with a anthim market share, detailed anthim market segments, market trends, and opportunities, and any further data you may need to thrive in the anthim industry. This anthim market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anthim market size is expected to see strong growth in the next few years. It will grow to $5,715.3 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to enhancing monoclonal antibody production, expanding healthcare infrastructure in emerging markets, and increasing global awareness of biological threat mitigation strategies. Major trends in the forecast period include advanced biopharmaceutical research, expanding public-private partnerships in biodefense initiatives, rising regional diversification in pharmaceutical production, and an emphasis on streamlined regulatory pathways to accelerate drug approval processes.

The rising prevalence of bacterial infections is expected to drive the growth of the anthim market. Bacterial infections, which occur when harmful bacteria invade the body, multiply, and produce toxins, are on the rise due to factors such as antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Anthim is a monoclonal antibody used to treat inhalation anthrax, a bacterial infection caused by Bacillus anthracis. It works by neutralizing the anthrax toxin and preventing it from entering cells, thus mitigating its harmful effects. For example, a report from the World Health Organization (WHO) in December 2023 revealed a significant increase in suspected anthrax cases in Zambia, from 42 cases between September 2022 and January 2023 to 684 cases by November 2023, including four deaths. This rising prevalence of bacterial infections, particularly anthrax, is a key factor fueling the growth of the anthim market.

A key trend in the anthim market is the adoption of strategic international contracts, such as public-private partnerships (PPPs), to enhance technology integration and expand market reach. PPPs involve collaborations between government agencies and private pharmaceutical companies to jointly fund, research, and distribute medical treatments, often addressing public health needs. For instance, in April 2022, Heat Biologics, a US-based biotechnology company, secured a $5.65 million contract with the Canadian government through its subsidiary Elusys Therapeutics. This contract involved supplying Anthim for the Canadian National Emergency Strategic Stockpile, marking the drug's first international procurement aimed at combating anthrax biothreats.

In April 2022, Heat Biologics, a US-based biotechnology company that offers pharmaceuticals, acquired Elusys Therapeutics expanding its biodefense portfolio. The acquisition allowed Heat Biologics to integrate Anthim into its RapidVax platform, enhance its manufacturing capabilities at a new facility in Kansas, and explore expanded global distribution opportunities. These developments highlight the growing strategic importance of Anthim in addressing anthrax threats and its potential for wider global distribution through partnerships and acquisitions.

Major players operating in the anthim market are Elusys Therapeutics Inc, and Hikma Pharmaceutical.

North America was the largest region in the anthim market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anthim report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anthim market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anthim market consists of sales of monoclonal antibodies, injectable solutions and emergency response treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anthim Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anthim market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anthim ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anthim market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Adult; Children
2) By Clinical Indications: Inhalational Anthrax Treatment; Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax; Use In Pediatric And Adult Populations
3) By Application: Hospital; Drugs Store; Other Applications
Companies Mentioned: Elusys Therapeutics Inc; Hikma Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33062

1. Executive Summary

2. Anthim Market Characteristics

3. Anthim Market Biologic Drug Characteristics

3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy

4. Anthim Market Trends And Strategies

5. Anthim Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Anthim Growth Analysis And Strategic Analysis Framework

6.1. Global Anthim PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Anthim Market Growth Rate Analysis
6.4. Global Anthim Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Anthim Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Anthim Total Addressable Market (TAM)

7. Global Anthim Market Pricing Analysis & Forecasts

8. Anthim Market Segmentation

8.1. Global Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Children
8.2. Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalational Anthrax Treatment
Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax
Use In Pediatric And Adult Populations
8.3. Global Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Drugs Store
Other Applications

9. Global Anthim Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications

10. Anthim Market Regional And Country Analysis

10.1. Global Anthim Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Anthim Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Anthim Market

11.1. Asia-Pacific Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Anthim Market

12.1. China Anthim Market Overview
12.2. China Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Anthim Market

13.1. India Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Anthim Market

14.1. Japan Anthim Market Overview
14.2. Japan Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Anthim Market

15.1. Australia Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Anthim Market

16.1. South Korea Anthim Market Overview
16.2. South Korea Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Anthim Market

17.1. Western Europe Anthim Market Overview
17.2. Western Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Anthim Market

18.1. UK Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Anthim Market

19.1. Germany Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Anthim Market

20.1. France Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anthim Market

21.1. Eastern Europe Anthim Market Overview
21.2. Eastern Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Anthim Market

22.1. North America Anthim Market Overview
22.2. North America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Anthim Market

23.1. USA Anthim Market Overview
23.2. USA Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Anthim Market

24.1. Canada Anthim Market Overview
24.2. Canada Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Anthim Market

25.1. South America Anthim Market Overview
25.2. South America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Anthim Market

26.1. Middle East Anthim Market Overview
26.2. Middle East Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Anthim Market

27.1. Africa Anthim Market Overview
27.2. Africa Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Anthim Market Competitive Landscape And Company Profiles

28.1. Anthim Market Competitive Landscape
28.2. Anthim Market Company Profiles
- 28.2.1. Elusys Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis
- 28.2.2. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Anthim Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Anthim Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Anthim Market

32. Recent Developments In The Anthim Market

33. Anthim Market High Potential Countries, Segments and Strategies

33.1 Anthim Market In 2029 - Countries Offering Most New Opportunities
33.2 Anthim Market In 2029 - Segments Offering Most New Opportunities
33.3 Anthim Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. The Business Research Company
34.6. Copyright And Disclaimer